BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 15738453)

  • 1. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study.
    Sarnak MJ; Greene T; Wang X; Beck G; Kusek JW; Collins AJ; Levey AS
    Ann Intern Med; 2005 Mar; 142(5):342-51. PubMed ID: 15738453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.
    Peterson JC; Adler S; Burkart JM; Greene T; Hebert LA; Hunsicker LG; King AJ; Klahr S; Massry SG; Seifter JL
    Ann Intern Med; 1995 Nov; 123(10):754-62. PubMed ID: 7574193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summaries for patients. A low blood pressure target prevented kidney failure in patients with chronic kidney disease.
    Ann Intern Med; 2005 Mar; 142(5):I42. PubMed ID: 15738448
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.
    Klahr S; Levey AS; Beck GJ; Caggiula AW; Hunsicker L; Kusek JW; Striker G
    N Engl J Med; 1994 Mar; 330(13):877-84. PubMed ID: 8114857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study.
    Levey AS; Greene T; Sarnak MJ; Wang X; Beck GJ; Kusek JW; Collins AJ; Kopple JD
    Am J Kidney Dis; 2006 Dec; 48(6):879-88. PubMed ID: 17162142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.
    Jafar TH; Stark PC; Schmid CH; Landa M; Maschio G; de Jong PE; de Zeeuw D; Shahinfar S; Toto R; Levey AS;
    Ann Intern Med; 2003 Aug; 139(4):244-52. PubMed ID: 12965979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trial.
    Davis EM; Appel LJ; Wang X; Greene T; Astor BC; Rahman M; Toto R; Lipkowitz MS; Pogue VA; Wright JT;
    Hypertension; 2011 Jun; 57(6):1061-8. PubMed ID: 21555676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study.
    J Am Soc Nephrol; 1996 Oct; 7(10):2097-109. PubMed ID: 8915969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strict blood-pressure control and progression of renal failure in children.
    ; Wühl E; Trivelli A; Picca S; Litwin M; Peco-Antic A; Zurowska A; Testa S; Jankauskiene A; Emre S; Caldas-Afonso A; Anarat A; Niaudet P; Mir S; Bakkaloglu A; Enke B; Montini G; Wingen AM; Sallay P; Jeck N; Berg U; Caliskan S; Wygoda S; Hohbach-Hohenfellner K; Dusek J; Urasinski T; Arbeiter K; Neuhaus T; Gellermann J; Drozdz D; Fischbach M; Möller K; Wigger M; Peruzzi L; Mehls O; Schaefer F
    N Engl J Med; 2009 Oct; 361(17):1639-50. PubMed ID: 19846849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study.
    Levey AS; Adler S; Caggiula AW; England BK; Greene T; Hunsicker LG; Kusek JW; Rogers NL; Teschan PE
    Am J Kidney Dis; 1996 May; 27(5):652-63. PubMed ID: 8629624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group.
    Lazarus JM; Bourgoignie JJ; Buckalew VM; Greene T; Levey AS; Milas NC; Paranandi L; Peterson JC; Porush JG; Rauch S; Soucie JM; Stollar C
    Hypertension; 1997 Feb; 29(2):641-50. PubMed ID: 9040451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.
    Jafar TH; Schmid CH; Landa M; Giatras I; Toto R; Remuzzi G; Maschio G; Brenner BM; Kamper A; Zucchelli P; Becker G; Himmelmann A; Bannister K; Landais P; Shahinfar S; de Jong PE; de Zeeuw D; Lau J; Levey AS
    Ann Intern Med; 2001 Jul; 135(2):73-87. PubMed ID: 11453706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study.
    Menon V; Kopple JD; Wang X; Beck GJ; Collins AJ; Kusek JW; Greene T; Levey AS; Sarnak MJ
    Am J Kidney Dis; 2009 Feb; 53(2):208-17. PubMed ID: 18950911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
    Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Blood Pressure Control on Long-Term Risk of End-Stage Renal Disease and Death Among Subgroups of Patients With Chronic Kidney Disease.
    Ku E; Sarnak MJ; Toto R; McCulloch CE; Lin F; Smogorzewski M; Hsu CY
    J Am Heart Assoc; 2019 Aug; 8(16):e012749. PubMed ID: 31411082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term effects of blood pressure control and antihypertensive drug regimen on glomerular filtration rate: the African-American Study of Kidney Disease and Hypertension Pilot Study.
    Hall WD; Kusek JW; Kirk KA; Appel LJ; Schulman G; Agodoa LY; Glassock R; Grim C; Randall OS; Massry SG
    Am J Kidney Dis; 1997 May; 29(5):720-8. PubMed ID: 9159306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood Pressure, Chronic Kidney Disease Progression, and Kidney Allograft Failure in Kidney Transplant Recipients: A Secondary Analysis of the FAVORIT Trial.
    Malhotra R; Katz R; Weiner DE; Levey AS; Cheung AK; Bostom AG; Ix JH
    Am J Hypertens; 2019 Aug; 32(9):816-823. PubMed ID: 31179500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.